Novo Nordisk is committed to providing information to help HCPs as they navigate through understanding what Tresiba® may offer their patients with diabetes. Below are videos and articles that were created to demonstrate why experts in the field have chosen to prescribe Tresiba®.
Hear from your peers
Tresiba® Speaker Series
with James R. Gavin, III, MD, PhD
The Tresiba® Speaker Series features industry leader Dr Gavin covering the clinical pharmacology of Tresiba®, including the mechanism of protraction and duration of action.
In the Basal Insights article and video series, diabetes-care experts discuss key topics related to prescribing Tresiba® for adult patients, featuring endocrinologist Dr Steven Edelman and primary care physician Dr Stephen Brunton.